MTOR and asthma: Furthermore, increased IL-33 expression in bronchial biopsy specimens has been suggested as a clinical marker of severe asthma.2,3 Moreover, rapamycin was effective at inhibiting T-cell responses from glucocorticoid-refractory asthmatic patients,45 whereas mTOR activity is required for mast cell cytokine production and cell survival.46